NIH-funded research R21 grant

Finding small molecules that bind to RNA in living bacteria

Official title: Novel approach to identify RNA-bound small molecules in vivo

Funded at New York University School of Medicine · NIH-10766276 · Data updated 2026-11-12

This study is exploring a new way to find tiny molecules that can attach to important RNA in bacteria, which could help create better antibiotics for treating tough infections.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startJanuary 19, 2023
Project endDecember 31, 2025
Funding year2024
Award (this year)$211,875
NIH project number5R21AI176122-02
Project IDNIH-10766276 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from infections caused by antibiotic-resistant bacteria.

Less likely to help

Patients with infections caused by non-bacterial pathogens or those who do not have antibiotic-resistant infections may not benefit from this research.

What this research studies

This research focuses on developing a new method to identify small molecules that bind to RNA within bacterial cells. By targeting specific RNA structures that are crucial for the survival and virulence of pathogens, the study aims to enhance the discovery of potential antibiotic treatments. The approach involves using natural regulatory RNAs and RNA aptamers to capture these small molecules, which could lead to more effective therapies against infections caused by bacteria with high mutation rates. This innovative methodology seeks to bridge the gap between laboratory findings and real-world applications in treating bacterial infections.

Why it matters

Potential benefit: If successful, this research could lead to the development of new antibiotics that are more effective against resistant bacterial infections.

How similar studies have gone: While the approach of targeting RNA with small molecules is promising, it is relatively novel and has not been extensively tested in vivo, indicating a potential for groundbreaking advancements.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Serganov, Alexander — New York University School of Medicine
  • Study coordinator: Serganov, Alexander

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.